Company

PharmaEssentia Corp

Headquarters: Taipei, Taiwan

CEO: Mr. Ko-Chung Lin Ph.D.

TWSE: 6446

Market Cap

TW$118.17 Billion

TWD as of Jan. 1, 2024

US$3.85 Billion

Market Cap History

PharmaEssentia Corp market capitalization over time

Evolution of PharmaEssentia Corp market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of PharmaEssentia Corp

Detailed Description

PharmaEssentia Corporation engages in the research, development, production, and sale of therapeutic products for the treatment of human diseases. Its products include BESREMi (ropeginterferon alfa-2b) that is used for the treatment of polycythemia vera, essential thrombocythemia, and hepatitis B and C; and Anti-PD-1 antibody for the treatment of cancer. The company also licensed to develop Oraxol for the treatment of breast, advanced gastric, and esophageal cancer; and KX01 for the treatment of psoriasis and actinic keratosis. It also focuses on the drug research and development programs in the areas of hematology, infectious disease, oncology, and dermatology. The company sold its products in Germany, Austria, the United Kingdom, France, Denmark, the Czech Republic, and Sweden. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

PharmaEssentia Corp has the following listings and related stock indices.


Stock: TWSE: 6446 wb_incandescent

Details

Headquarters:

No. 3, park Street

2nd Floor-5 Nangang District

Taipei, 115

Taiwan

Phone: 886 2 2655 7688

Fax: 886 2 2655 7626